Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
To mitigate the loss of lives during the COVID-19 pandemic, emergency use authorization
was given to several anti-SARS-CoV-2 monoclonal antibody (mAb) therapies for the …
was given to several anti-SARS-CoV-2 monoclonal antibody (mAb) therapies for the …